Business bookshelves groan under the weight of success stories. Every year, another title promises to decode the habits of winning companies and visionary leaders. But there’s a curious blind spot in all this optimism: almost nobody writes about why the vast majority of companies end up mediocre, stagnant, or dead.

The numbers tell a sobering story. The average lifespan of an S&P 500 company has more than halved since the late 1970s. The rate at which firms fall out of the Fortune 100 has risen by roughly 60% over the past fifty years. Household names in banking, retail, media, and technology have vanished-some absorbed by rivals, others left to wither, and many driven into bankruptcy.

The historian Arnold Toynbee once observed that civilisations rarely fall because of external invaders; they collapse because of internal rot. Corporations follow the same pattern. Recessions, regulatory shifts, and disruptive technology may land the final blow, but they almost always strike a body already weakened from within.

This article examines the eight internal diseases that silently corrode companies-and offers a practical leadership framework for detecting and treating each one before it becomes terminal.

The Four Diseases of Corporate Decline

When leaders of struggling companies are asked what went wrong, the answer almost always points outward: a sudden market shift, a predatory competitor, an unforeseen crisis. These explanations have the comfort of being partially true and entirely misleading. In the overwhelming majority of cases, external shocks merely expose weaknesses that were already festering inside the organisation.

Four recurring patterns account for the most visible forms of corporate decline: strategic blindness, organisational inertia, siloed individualism, and internal warfare. But beneath these sit four deeper, slower-acting diseases that are equally lethal: founder dependency, cultural arrogance, talent drain, and short-termism. Think of them as the eight chronic diseases of the corporate body. Left untreated, any one of them is enough to kill a company. In combination, they are almost always fatal.

Disease #1: Strategic Blindness

Strategic blindness is the failure to see- or acknowledge-that the world has changed around you. It doesn’t always look like ignorance. Often it looks like confidence: a deep, unshakeable belief that what worked yesterday will work tomorrow.

What it looks like in practice:

• Leadership treats the annual strategy review as a ritual rather than a genuine interrogation of the business model.
• Customer feedback that contradicts internal assumptions gets dismissed as “noise.”
• Executives benchmark exclusively against familiar competitors, ignoring adjacent industries and emerging players.
• Investment decisions are anchored to historical performance rather than forward-looking market signals.

Real-world example – Nokia: In 2007, Nokia commanded roughly 50% of the global mobile phone market. Its handsets were everywhere, from Helsinki to Hyderabad. But when Apple launched the iPhone that same year, Nokia’s leadership dismissed it as a niche luxury product that would never appeal to the mass market. Internally, the company remained anchored to its belief that hardware durability and network reliability mattered more than software ecosystems and touchscreen interfaces. By the time Nokia’s executives accepted that the smartphone revolution was real, Android and iOS had captured the market. Nokia sold its phone division to Microsoft in 2014 for a fraction of its former value. The technology was available to Nokia. What was missing was the strategic imagination to see that the rules of the game had fundamentally changed.

Disease #2: Organisational Inertia

Even when companies craft brilliant strategies, thousands of them never translate those plans into action. Strategy decks gather dust while the organisation continues operating on muscle memory. The gap between intention and execution is where most corporate ambitions go to die.

What it looks like in practice:

• Middle managers are overwhelmed with day-to-day operations and see strategic initiatives as an additional burden rather than core work.
• Previous change efforts failed or fizzled out, creating deep organisational cynicism: “We’ve seen this movie before.”
• Leaders champion new ideas at town halls but don’t allocate the budget, talent, or political capital needed to make them real.
• The culture rewards predictability over experimentation, and people who try new things and fail are punished more than people who do nothing.

Real-world example – Kodak: Kodak is often cited as a company that missed the digital photography shift, but the truth is even more tragic. Kodak actually invented the first digital camera in 1975. Its engineers built working prototypes, filed patents, and produced internal reports warning that digital would eventually replace film. But the company’s leadership could never bring themselves to act on what they knew. Film accounted for the vast majority of Kodak’s profits, and every digital initiative faced resistance from the divisions it would cannibalise. Kodak had the strategy on paper. What it lacked was the organisational will to act on its own legacy. The company filed for bankruptcy in 2012, holding a portfolio of digital patents it had never fully commercialised.

Disease #3: Siloed Individualism

The word “company” itself comes from the Latin cum panis-breaking bread together. It is, by definition, a cooperative venture. Yet many modern corporations have devolved into loose collections of fiefdoms, where divisions, functions, and regions operate as separate kingdoms that compete for resources and credit rather than collaborate for shared success.

What it looks like in practice:

• Executives hoard information and talent within their units, treating internal knowledge as a proprietary advantage over colleagues.
• Cross-functional projects move at glacial speed because nobody has the authority or incentive to drive them.
• The customer experiences a different company depending on which division they interact with.
• Leaders say, “The people in our unit do a better job. We don’t need those other teams. They just slow us down.”

Real-world example – Sony: In the early 2000s, Sony was a powerhouse with world-class divisions in music, film, gaming, electronics, and computing. But each division operated as an independent empire. The electronics team refused to adopt the MP3 format because it threatened Sony Music’s CD revenues. The result? Apple’s iPod conquered a market that Sony, the company that invented the Walkman, should have owned. Sony’s television, camera, and computing divisions competed with one another for components and shelf space rather than building integrated products. It wasn’t until Kazuo Hirai took over as CEO in 2012 and forced painful cross-divisional collaboration under the “One Sony” strategy that the company began its turnaround. The talent and technology were always there. What was missing was the institutional willingness to share.

Disease #4: Internal Warfare

Healthy competition between ambitious people can be a powerful engine of innovation. But when personal rivalries metastasise into factional warfare, when executives badmouth each other in meetings, issue contradictory orders, or simply refuse to cooperate, the damage can be existential.

What it looks like in practice:

• Senior leaders publicly or privately undermine each other’s initiatives, creating confusion down the ranks.
• Decisions get relitigated endlessly because competing power centres refuse to accept outcomes that don’t favour them.
• Talented people leave because they are exhausted by political manoeuvring that has nothing to do with serving customers.
• The conflict eventually spills into the boardroom, the media, or both, damaging the company’s reputation with investors and the public.

Real-world example – Hewlett-Packard: Few companies illustrate the cost of boardroom warfare better than HP in the 2010s. A series of CEO changes-Mark Hurd’s resignation, Léo Apotheker’s brief and turbulent tenure, and the subsequent power struggles under Meg Whitman-created a leadership vacuum that rippled through the entire organisation. Board members leaked confidential discussions to the press. Executives pursued contradictory strategies depending on which faction held temporary sway. The disastrous acquisition of Autonomy, which led to an $8.8 billion write-down, was partly a product of a board too divided to conduct proper due diligence. HP eventually split into two companies in 2015, but years of infighting had already cost the firm billions in market value and driven away top engineering talent to competitors such as Dell and Amazon Web Services.

Disease #5: Founder Dependency

In the early stages, a charismatic founder is an asset. They set the vision, attract talent, close deals, and embody the brand. But when the entire organisation is built around a single individual-when no decision can be made without their approval, no culture exists independent of their personality, and no succession plan is in place-the company becomes dangerously fragile.

What it looks like in practice:

• The founder makes every significant decision personally, from product design to office furniture, creating bottlenecks across the organisation.
• The board functions as a rubber stamp rather than an independent governing body, unable or unwilling to challenge the founder’s judgment.
• No credible successor exists because the founder has neither invested in developing one nor actively undermined potential rivals.
• The company’s brand, investor confidence, and employee morale are all tied to one person’s presence rather than to institutional capability.

Real-world example – WeWork: At its peak in early 2019, WeWork was valued at $47 billion. Its co-founder, Adam Neumann, had built the company on sheer force of personality, convincing investors, employees, and the market that a commercial real estate subleasing business was actually a world-changing technology company. But the organisation was Neumann. He made unilateral decisions on everything from acquisitions to office aesthetics, engaged in self-dealing transactions (trademarking the word “We” and charging his own company $5.9 million to license it), and presided over a governance structure that gave the board almost no real power. When WeWork filed its IPO prospectus in August 2019, investors saw the reality: $1.9 billion in losses, conflicts of interest at every level, and no path to profitability. The valuation collapsed to under $10 billion within weeks. Neumann was forced out, and WeWork eventually filed for bankruptcy in 2023.

Disease #6: Cultural Arrogance

Success is the most dangerous drug in business. When a company has been winning for so long that its people begin to believe their methods are permanent laws rather than temporary advantages, the organisation develops a kind of institutional hubris. Past performance becomes a substitute for present alertness. The very culture that enabled success becomes the culture that prevents adaptation.

What it looks like in practice:

• Leadership treats historical success as proof that current methods are correct, rather than as evidence that they were correct in a specific context that may have changed.
• Internal management systems and processes are treated as sacred and unquestionable, even when the business environment has fundamentally shifted.
• The organisation produces leaders who are clones of each other, trained in the same internal academy, promoted through the same metrics, blind to the same assumptions.
• External criticism is dismissed as ignorance: “They don’t understand our business. We’re GE / IBM / [insert name]. We know what we’re doing.”

Real-world example – General Electric: Under Jack Welch, GE was the most admired company in the world. Its management academy at Crotonville was considered the equal of top business schools. Its forced-ranking system, acquisition-driven growth model, and relentless focus on shareholder value became the playbook that corporate America tried to copy. But this very success bred a dangerous arrogance. GE’s leaders came to believe that the “GE system” could make any business work in any context. When Jeff Immelt succeeded Welch in 2001, he inherited a model that had already reached the limits of its effectiveness. The company had become dangerously financialised through GE Capital, its management culture rewarded short-term metrics over long-term resilience, and the institutional confidence was so deep that questioning the model felt like heresy. GE’s market capitalisation fell from over $500 billion to under $100 billion. In 2018, it was removed from the Dow Jones index for the first time in over a century, and in 2021, it announced its break-up into three separate companies.

Disease #7: Talent Drain

The most dangerous exodus in any organisation is the one nobody notices. Before the crisis becomes visible to the board, before revenue starts to decline, before customers begin to complain, the best people have already left. They leave quietly, without drama, often for opportunities that seem only marginally better. But their departure is a leading indicator: talented people have the options and the awareness to sense organisational decay before it shows up in the numbers.

What it looks like in practice:

• Top performers leave in clusters, often to the same competitor, but leadership dismisses each departure as an isolated event.
• Exit interview data reveals consistent themes-lack of autonomy, political culture, stalled innovation-but the findings are filed and forgotten.
• The company replaces departing stars with cheaper or more compliant hires, gradually lowering the talent baseline without realising it.
• Institutional knowledge walks out the door with every departure, but nobody has documented it or built systems to retain it.

Real-world example – Yahoo: Yahoo’s decline is often told as a story of missed acquisitions, turning down the chance to buy Google for $1 million in 1998, then again for $5 billion in 2002. But the deeper story is one of talent haemorrhage. Through the 2000s and early 2010s, Yahoo’s best engineers and product leaders left in waves for Google, Facebook, and startups. Each departure weakened the company’s ability to innovate, making the workplace less attractive and triggering further departures. By the time Marissa Mayer arrived as CEO in 2012, the talent pipeline had been so thoroughly drained that no amount of strategic vision could compensate for the missing capability. Yahoo’s core business was eventually sold to Verizon in 2017 for approximately $4.5 billion-a fraction of the $125 billion the company had been worth at its peak.

Disease #8: Short-Termism

When quarterly earnings become the primary measure of leadership success, everything else-safety, quality, employee development, long-term R&D-gets subordinated to the next reporting cycle. The logic is seductive: if we don’t hit this quarter’s numbers, there won’t be a long term. But the cumulative effect of thousands of small decisions optimised for the short term is an organisation that has hollowed itself out from the inside.

What it looks like in practice:

• Investment in R&D, training, and quality systems is treated as a cost to be minimised rather than a capability to be built.
• Leaders who meet quarterly targets are rewarded regardless of how they achieved them or what long-term risks they accumulated in the process.
• Engineers and front-line staff raise safety or quality concerns, but these are overridden by schedules and budgets controlled by executives whose bonuses are tied to delivery dates.
• The company gradually replaces experienced, expensive employees with cheaper ones, losing institutional knowledge and craftsmanship in the process.

Real-world example – Boeing: Boeing’s transformation from an engineering-first culture to a finance-first culture is one of the most consequential examples of short-termism in modern business. Following its 1997 merger with McDonnell Douglas, Boeing’s leadership increasingly prioritised cost reduction, shareholder returns, and production speed over engineering rigour. The company moved its headquarters from Seattle, where engineers lived and worked, to Chicago, creating a physical and cultural distance between executives and the people who built aeroplanes. The consequences were catastrophic. The 737 MAX was rushed to market to compete with Airbus, and its MCAS flight-control system, designed to compensate for an aerodynamic compromise driven by cost constraints, was built with a single sensor and hidden from pilots. Two crashes in 2018 and 2019 killed 346 people. Boeing has since incurred over $20 billion in losses, faced criminal fraud charges, and weathered a reputational crisis that may take a generation to repair.

The Leadership Cure: An Eight-Point Treatment Plan

Diagnosis without treatment is merely an autopsy. The eight diseases described above are not destiny-they are tendencies that can be managed, contained, and reversed if leaders are willing to be honest with themselves. Below is a practical framework for doing exactly that.

1. Build a Living Strategy, Not a Static Document

Too many organisations treat strategy as an annual ritual: a polished deck produced over three months that becomes obsolete within weeks. The antidote is what might be called strategic curiosity-an organisational habit of perpetual questioning.

Practical actions:

• Schedule quarterly “assumption audits” in which the leadership team identifies the three biggest beliefs underpinning the business and pressure-tests each with fresh data.
• Bring in voices from outside your industry-adjacent sectors, academia, and even customers, to challenge internal groupthink.
• Reward people who flag uncomfortable truths early, rather than punishing the messengers.
• Study companies that died in your sector and ask: “At what point did their leadership miss the signal?” Then ask: “Are we missing a similar signal right now?”

2. Convert Vision into Relentless Execution

Having a vision is easy. Making it real is brutally hard. The gap between strategy and execution is the single most common place where corporate ambitions die. The enemy here is not stupidity-it is drift: the slow, almost imperceptible loss of energy that turns strong intentions into weak outcomes.

Practical actions:

• Break every strategic priority into quarterly deliverables with named owners and visible accountability.
• Celebrate progress publicly, but be equally willing to confront stalled initiatives-and kill them if they are no longer viable.
• Make experimentation safe, but make passivity uncomfortable. People who try and fail should be treated better than people who never try at all.
• Leaders must model the behaviours they demand. If the CEO asks for speed but takes three weeks to approve a budget, the organisation will mirror the delay rather than the rhetoric.

3. Design the Organisation to Win Together

Individual brilliance can create momentum, but only collective action can sustain it. Yet many companies inadvertently reward solo operators over bridge builders, and when they do, silos harden, cooperation fades, and the organisation slowly fragments into competing tribes.

Practical actions:

• Redesign incentive structures so that a meaningful portion of every leader’s bonus depends on enterprise-wide outcomes, not just their own unit’s performance.
• Rotate high-potential leaders across functions and geographies so they learn to see the company as a system, not a collection of territories.
• Invest real time, not just off-site dinners, in building trust among the top team. Trust is what allows disagreement without disloyalty.
• When customers interact with your company, they should experience one brand and one standard of service, not a patchwork of fiefdoms with different cultures.

4. Manage Conflict Before It Manages You

Disagreement is not the enemy. Dysfunction is. Passionate debate about strategy, priorities, and resource allocation is healthy-even necessary. The problem begins when honest debate degenerates into personal vendettas, shadow campaigns, and factional power plays.

Practical actions:

• Create structured forums where differences of opinion surface early and in the open, rather than festering in hallway conversations.
• Clarify decision rights explicitly so that authority is never contested in the shadows. Everyone should know who decides, who advises, and who executes.
• Confront interpersonal friction between senior leaders promptly. Hoping that two warring executives will sort it out on their own is almost always a losing bet.
• When resolution is impossible, act decisively. Keeping two competing lieutenants as a long-term insurance policy sounds prudent, but usually ends with both failing and dragging the organisation down with them.

5. Build the Institution, Not the Cult

Founders create companies. Institutions sustain them. The transition from founder-led to institutionally governed is one of the hardest passages in corporate life, and many companies never make it.

Practical actions:

• Begin succession planning years before it is needed. Identify and develop at least two credible internal candidates who could step into the top role.
• Establish a genuinely independent board with members who have the stature and willingness to challenge the founder’s decisions.
• Separate the founder’s personal brand from the company’s brand. If the company cannot survive the departure of a single person, it is not a company-it is a dependency.
• Create governance guardrails that prevent self-dealing and conflicts of interest, regardless of how much value the founder has created.

6. Stay Paranoid, Even When You’re Winning

Andy Grove of Intel famously said that only the paranoid survive. Cultural arrogance is the opposite of paranoia-it is the conviction that your success is structural rather than situational. The antidote is deliberate institutional humility.

Practical actions:

• Regularly bring in external voices-customers, competitors, academics, even critics-to challenge internal orthodoxies.
• Commission periodic “pre-mortem” exercises: ask your leadership team to imagine the company has failed in five years, then work backwards to identify what caused it.
• Rotate high-potential leaders through external assignments, advisory roles, or sabbaticals so they are exposed to how the world outside the company actually works.
• Treat your management playbook as a living document that must be updated every few years, not as a sacred text to be preserved.

7. Treat Talent Retention as a Leading Indicator

Revenue decline is a lagging indicator. Customer complaints are a lagging indicator. Talent departure is a leading indicator. If your best people are leaving, something is already broken-you just can’t see it in the P&L yet.

Practical actions:

• Track voluntary attrition among your top 20% performers as a board-level metric, not just an HR statistic.
• Conduct “stay interviews” with your best people regularly-don’t wait until they hand in their notice to ask what they need.
• Create meaningful career paths that don’t require people to leave the company to grow. If the only way up is out, that is a design failure.
• Invest in institutional knowledge management. When a key person leaves, the damage should be felt in relationships and judgment, not in the loss of information that was only in their head.

8. Protect the Long Term from the Tyranny of the Quarter

Short-termism is not an individual failing. It is a systemic one, baked into incentive structures, reporting cycles, and investor expectations. Defeating it requires deliberate structural intervention.

Practical actions:

• Tie a meaningful portion of executive compensation to three-to-five-year outcomes, not quarterly results. What gets measured gets managed-and what gets rewarded gets prioritised.
• Ring-fence R&D and safety budgets so they cannot be raided to meet short-term earnings targets. Make these budgets visible to the board.
• Create an independent quality or safety function that reports directly to the board, not to the CEO. The people responsible for quality must not report to the people responsible for speed.
• Have the courage to communicate honestly with investors about the trade-offs between short-term performance and long-term capability. The best investors will respect transparency; the worst were never your allies anyway.

The Hardest Question a Leader Can Ask

Every CEO faces moments when the outside world feels hostile-new competitors, shifting regulations, volatile markets, activist shareholders. It is natural to blame the environment. But the most important act of leadership is to look inward and ask: “What part of this do I own?”

Great leaders institutionalise self-reflection. They invite tough feedback from their teams and boards. They commission cultural audits not as compliance exercises but as tools for surfacing uncomfortable truths. They start meetings by asking “What’s not working?” rather than “What went well?” And they set a personal example by admitting their own missteps first.

This is not a weakness. It is an operating advantage. When a leader shows vulnerability, it gives everyone else permission to speak honestly. And only when people speak honestly can the organisation detect the internal diseases early enough to treat them.

Defeating the enemy within is not a one-time campaign or a restructuring project with a finish date. It is a state of mind-a daily discipline of self-awareness, organisational honesty, and relentless execution. Companies that master this discipline don’t just survive disruption. They emerge from it stronger than before.

The destiny of your company is in your hands. The sooner you stop looking for enemies at the gate and start looking for them in the mirror, the sooner you’ll find the path to lasting success.

Bibliography

Bürkner, H-P., Bailey, A., Chua, J. and Hoteit, L. (2026) ‘The Enemy Is (Almost) Always Within,’ Boston Consulting Group, 17 March. Available at: https://www.bcg.com/publications/2026/the-enemy-is-almost-always-within-a-company

Alcacer, J., Khanna, T. and Snively, C. (2014) ‘The Rise and Fall of Nokia,’ Harvard Business School Case 714-428. Available at: https://www.hbs.edu/faculty/Pages/item.aspx?num=46041

Lamberg, J-A. et al. (2019) ‘The Curse of Agility: The Nokia Corporation and the Loss of Market Dominance in Mobile Phones, 2003–2013,’ Business History. Available at: https://www.tandfonline.com/doi/full/10.1080/00076791.2019.1593964

Gavetti, G., Henderson, R. and Giorgi, S. (2005) ‘Kodak and the Digital Revolution,’ Harvard Business School Case 705-448. Referenced via: https://pradeepsingh.com/kodak-digital-revolution/

McGregor, J. (2012) ‘In Kodak Bankruptcy, Another Casualty of the Digital Revolution,’ TIME, 20 January. Available at: https://business.time.com/2012/01/20/in-kodak-bankruptcy-another-casualty-of-the-digital-revolution/

‘Kodak: A Cautionary Tale of Corporate Myopia’ (2023) The CDO Times, 27 September. Available at: https://cdotimes.com/2023/09/27/case-study-kodaks-downfall-a-lesson-in-failed-digital-transformation-and-missed-opportunities/

Cojocaru, C. and Cojocaru, S. (2014) ‘Sony vs. Apple – iPod Launching, a Case Study of Leadership and Innovation,’ Manager Journal, Faculty of Business and Administration, University of Bucharest, vol. 20(1). Available at: https://ideas.repec.org/a/but/manage/v20y2014i1p115-125.html

Hasan, D. (2009) ‘Why Sony Missed the iPod – The Curse of Silos,’ Ideas Inspiring Innovation, 30 December. Available at: https://ideasinspiringinnovation.wordpress.com/2009/12/30/why-sony-missed-the-ipod-the-curse-of-silos/

Solis, B. (2013) ‘The Rise and Fall of Sony, Panasonic, and Sharp and How to Survive Digital Darwinism,’ BrianSolis.com. Available at: https://briansolis.com/2013/12/the-rise-and-fall-of-sony-panasonic-and-sharp-and-how-to-survive-digital-darwinism/

‘The HP–Autonomy Lawsuit: Timeline of an M&A Disaster’ (2025) CIO. Available at: https://www.cio.com/article/304397/the-hp-autonomy-lawsuit-timeline-of-an-ma-disaster.html

‘HP Autonomy,’ Wikipedia. Available at: https://en.wikipedia.org/wiki/HP_Autonomy

‘Hewlett Packard’s Disastrous Acquisition of Autonomy Heads to Trial’ (2024) Fortune, 18 March. Available at: https://fortune.com/2024/03/18/hewlett-packard-disastrous-acquisition-autonomy-trial-court-explores-whether-deal-illegal-rip-off-botched-management/

‘Hewlett Packard: The Complete 80+ Year History’ History Tools. Available at: https://www.historytools.org/companies/hewlett-packard-history

‘The WeWork Collapse: Governance Failures, Founder Control & Lessons Learned’ Directors’ Institute. Available at: https://www.directors-institute.com/post/the-wework-collapse-governance-failures-founder-control-lessons-learned

Byrne, D. ‘What Exactly Happened to WeWork?’ The Corporate Governance Institute. Available at: https://www.thecorporategovernanceinstitute.com/insights/case-studies/what-exactly-happened-to-wework/

‘Three Strategy Lessons from GE’s Decline’ Chicago Booth Review. Available at: https://www.chicagobooth.edu/review/three-strategy-lessons-ge-s-decline

Mohammed, S. (2025) ‘Divided We Stand: The Fall and Fracture of General Electric,’ Medium. Available at: https://shahmm.medium.com/divided-we-stand-the-fall-and-fracture-of-general-electric-0b3d378bb68f

‘Jack Welch’s Legacy: The Rise and Limitations of a Model’ (2026) Duperrin.com. Available at: https://www.duperrin.com/english/2026/01/23/ge-jack-welch/

Satell, G. (2024) ‘Why GE’s Incredible Turnaround Could Be a Sign of the Times,’ Medium. Available at: https://greg-satell.medium.com/why-ges-incredible-turnaround-could-be-a-sign-of-the-times-0328398e4ee4

Nartey, J. ‘The Boeing 737 MAX Crisis: An Ethical Analysis of Corporate Governance Failures,’ SSRN. Available at: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5316121

Herkert, J., Borenstein, J. and Miller, K. (2020) ‘The Boeing 737 MAX: Lessons for Engineering Ethics,’ Science and Engineering Ethics. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7351545/

‘The Story of Boeing’s Failed Corporate Culture’ (2025), The CPA Journal. Available at: https://www.cpajournal.com/2025/06/02/the-story-of-boeings-failed-corporate-culture/

Dolfing, H. (2024) ‘Case Study 19: The $20 Billion Boeing 737 Max Disaster,’ HenricoDolfing.com. Available at: https://www.henricodolfing.com/2024/08/case-study-19-20-billion-boeing-737-max.html

Hans-Paul Bürkner, Allison Bailey, Jeffrey Chua, and Leila Hoteit, The Enemy Is (Almost) Always Within”. BCG March 2026. Available at: https://www.bcg.com/publications/2026/the-enemy-is-almost-always-within-a-company

.